Evidence map›Paper›PMID 39061371›Full record

ArticleBrain sciences2024

Utilization of MANAGE-PD Tool in a Real-World Setting in Germany: A Cross-Sectional Study.

Martin Südmeyer, David J Pedrosa, Frank Siebecker, Carolin Arlt, Jaakko J Kopra, Wolfgang H Jost

Abstract read
In one paragraph

Article in Brain sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martin SüdmeyerDepartment of Neurology, Ernst-von-Bergmann Klinikum, 14467 Potsdam, Germany.
David J PedrosaDepartment of Neurology, Philipps-University Marburg, 35037 Marburg, Germany.
Frank SiebeckerPraxis Neurologie, 48291 Telgte, Germany.
Carolin ArltAbbVie GmbH, 1230 Wien, Austria.ORCID 0009-0005-6255-0686
Jaakko J KopraAbbVie Deutschland GmbH & Co. KG, 65189 Wiesbaden, Germany.ORCID 0000-0002-4872-3326
Wolfgang H JostParkinson-Klinik Ortenau, 77709 Wolfach, Germany.ORCID 0000-0002-8574-3297

Funding

AbbVie (Germany) N/A
6 · The paper itself

Abstract

MANAGE-PD is a validated, web-based tool to assist physicians in identifying patients with Parkinson's disease (PD) whose symptoms are inadequately controlled by oral medication. Also, a modified patient version of MANAGE-PD (Parkinson Check) is available in Germany. However, prospective research into the clinical utility of MANAGE-PD is lacking. This non-interventional study aimed to assess the real-world clinical utility of the MANAGE-PD and Parkinson Check in PD patients attending a single visit at specialist clinics and neurologist practices in Germany in 2022. Participants' disease control was rated by the physicians using their own judgment, and by completing the MANAGE-PD, and by the patients completing the Parkinson Check. Concordance was calculated between the unassisted physician's assessment and the outcome of MANAGE-PD, as well as the Parkinson Check. A total of 278 patients from 19 sites were included in the analyses, of whom 160 patients (57.6%) were assigned to the same category of disease control by physicians' judgment and the MANAGE-PD. Concordance was higher in patients treated in specialist clinics (63.9%) than in neurologist practices (43.7%). Concordance between physicians' and patients' responses was high (>80%) for each question in the Parkinson Check. MANAGE-PD proved to be especially valuable for general neurologists in identifying patients who should be referred to specialist clinics. The Parkinson Check self-assessment generated promising outcomes that merit its more widespread use.

Indexed as

clinical decision-makingdevice-aided therapyMANAGE-PDParkinson’s diseasepatient identificationphysician-patient concordance

Identifiers

PMID39061371
PMCPMC11275059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.